Show simple item record

Precision medicine in type 2 diabetes: harnessing individual-level trial data alongside routine care records to identify predictors of response to SGLT2 inhibitors and DPP4 inhibitors

dc.contributor.authorDennis, JM
dc.contributor.authorHenley, W
dc.contributor.authorJones, A
dc.contributor.authorMcGovern, A
dc.contributor.authorPearson, E
dc.contributor.authorHattersley, A
dc.contributor.authorShields, B
dc.date.accessioned2020-01-09T13:34:37Z
dc.date.issued2019-09-30
dc.identifier.citationVol. 62 (Issue 1 Supplement), p. S178, abstract 356en_GB
dc.identifier.doi10.1007/s00125-019-4946-6
dc.identifier.urihttp://hdl.handle.net/10871/40329
dc.language.isoenen_GB
dc.publisherSpringer Verlagen_GB
dc.rights.embargoreasonUnder embargo until 30 September 2020 in compliance with publisher policyen_GB
dc.rights© 2019 Springer Verlagen_GB
dc.titlePrecision medicine in type 2 diabetes: harnessing individual-level trial data alongside routine care records to identify predictors of response to SGLT2 inhibitors and DPP4 inhibitorsen_GB
dc.typeConference paperen_GB
dc.date.available2020-01-09T13:34:37Z
dc.identifier.issn0012-186X
dc.descriptionThis is the author accepted manuscript. The final version is available from Springer Verlag via the DOI in this recorden_GB
dc.description55th EASD Annual Meeting, Barcelona, Spain, 16–20 September 2019en_GB
dc.identifier.journalDiabetologiaen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2019-09-30
rioxxterms.typeConference Paper/Proceeding/Abstracten_GB
refterms.dateFCD2020-01-09T13:31:52Z
refterms.versionFCDAM
refterms.panelAen_GB


Files in this item

Name:
EASD_19_SGLT2vDPP4V1.0.pdf
Size:
42.35Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record